Trial Profile
An Open-label, Prospective, Uncontrolled Study of the Safety and Local Tolerability of the Diclofenac Epolamine Patch (Flector Patch) in Pediatric Patients With Minor Soft Tissue Injuries
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2021
Price :
$35
*
At a glance
- Drugs Diclofenac hydroxyethylpyrrolidine (Primary)
- Indications Pain
- Focus Adverse reactions
- 26 Nov 2021 The protocol was amended to increased the eligibility interval from < 48 to < 96 h after injury occurrence to increase the likelihood of enrolling children with an acute injury as per results published in the Clinical Drug Investigation
- 26 Nov 2021 Results published in the Clinical Drug Investigation
- 09 Apr 2018 Status changed from active, no longer recruiting to completed.